Project Details
Description
A Phase 1, Multicenter, Open Label Study of YM155 Plus Docetaxel and Prednisone in Men with Advanced Hormone Refractory Prostate Cancer (HRPC)
| Status | Finished |
|---|---|
| Effective start/end date | 3/12/07 → 5/19/09 |
Funding
- ASTELLAS PHARMA US, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.